Lasting reduction of severe spasticity after ending chronic treatment with intrathecal baclofen

Journal of Neurology Neurosurgery and Psychiatry

Volumn 60, Issue 2, 1996, Pages 168-173

  Dressnandt, Jürgen ^a   Conrad, Bastian ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Intrathecal baclofen; Spasticity

Indexed keywords

BACLOFEN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; INTRATHECAL DRUG ADMINISTRATION; LONG TERM CARE; MALE; MUSCLE SPASM; MUSCLE TONE; PRIORITY JOURNAL; SPASTICITY;

EID: 0030043529     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.60.2.168     Document Type: Article

References (29)

1. Penn RD, Kroin JS. Intrathecal baclofen alleviates spinal cord spasticity [letter]. Lancet 1984;i:1078.
2. Ochs G, Struppler A, Meyerson BA, et al. Intrathecal baclofen for long term treatment of spasticity: a multicentre study. J Neurol Neurosurg Psychiatry 1989;52: 933-9.
3. Loubser PG, Narayan RK, Sandin KJ, Donovan WH, Russell KID. Continuous infusion of intrathecal baclofen: long-term effects on spasticity in spinal cord injury. Paraplegia 1991;29:48-64.
4. Penn RD. Intrathecal baclofen for spasticity of spinal origin: seven years of experience. J Neurosurg 1992;77: 236-40.
5. Meythaler JM, Steers WD, Tuel SM, Cross LL, Haworth CS. Continuous intrathecal baclofen in spinal cord spasticity. A prospective study. Am J Phys Med Rehabil 1992; 71:321-7.
6. Coffey JR, Cahill D, Steers W, et al. Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-terra multicenter study. J Neurosurg 1993;78:226-32.
7. Zierski J, Müller H, Dralle D, Wurdinger T. Implanted pump systems for treatment of spasticity. Acta Neurochir Suppl (Wein) 1988;43:94-9.
8. Dressnandt J, Konstanzer A, Conrad B. Reversal of spasticity after longterm treatment with intrathecal baclofen. J Neurol 1992;239S3:37
9. Ashworth B. Preliminary trial of carisoprodol in multiple sclerosis. Practitioner 1964;192:540-2.
10. Lee KC, Carson L, Kinnin E, Patterson V. The Ashworth scale: a reliable and reproducible method of measuring spasticity. J Neurol Rehabil 1989;3:205-9.
11. Kroin JS, Penn RD. Implantable pumps to deliver drugs directly into the CNS. In: Neuwelt EA, ed. Implications of the blood-brain barrier and its manipulation. Vol 2. Clinical aspects. New York: Plenum Press, 1989:601-16.
12. Sallerin-Caute B, Lazorthes Y, Monsarrat B, Cros J, Bastide R. CSF baclofen levels after intrathecal administration in severe spasticity. Eur J Clin Pharmacol 1991;40: 363-5.
13. Kroin JS, Ali A, York M, Penn RD. The distribution of medication along the spinal canal after chronic intrathecal administration. Neurosurgery 1993;33:266.
14. Wilson PR, Yaksh TL. Baclofen is antinociceptive in the spinal intrathecal space of animals. Eur J Pharmacol 1978;51:323-30.
15. Yaksh TL, Reddy R. Studies in the primate on the analgesic effects with the intrathecal actions of opiates, adrenergic agonists and baclofen. Anesthesiology 1981;54: 451-67.
16. Kroin JS, Penn RD, Bessinger RL, Arzbaecher RC. Reduced spinal reflexes following intrathecal baclofen in the rabbit. Exp Brain Res 1984;54:191-4.
17. Bowery NG, Hill DR, Hudson AL, Doble A, Middlemiss DN, Shaw J, Turnbull M. (-)-Baclofen decreases neurotransmitter release in the mammalian CNS by action at a novel GABA receptor. Nature 1980;283:92-4.
18. Bowery NG, Pratt GD. GABAB receptors as targets for drug action. Arzneimittelforschung 1992;42:215-23.
19. Dolphin AC, Scott RH. Inhibition of calcium currents in cultured rat dorsal root ganglion neurones by (-)-baclofen. Br J Pharmacol 1986;88:213-20.
20. Kangrga I, Jiang M, Randic M. Actions of (-)-baclofen on rat dorsal horn neurons. Brain Res 1991;562:265-75.
21. Zimmermann H. Synaptic transmission. Cellular and molecular basis. New York: Oxford University Press, 1993:94-104.
22. Castro-Lopes JM, Tavares I, Tölle TR, Coito A, Coimbra A. Increase in GABAergic cells and GABA levels in the spinal cord in unilateral inflammation of the hindlimb in the rat. Eur J Neurosci 1992;4:296-301.
23. Castro-Lopes JM, Tavares I, Tölle TR, Coimbra A. Carrageenan-induced inflammation of the hind foot provokes a rise of GABA-immunoreactive cells in rat spinal cord that is prevented by peripheral neurectomy or neonatal capsaicin treatment. Pain 1994;56:193-201.
24. Tölle TR, Herdegen T, Schadrack J, Bravo R, Zimmermann M, Zieglgänsberger W. Application of morphine prior to noxious stimulation differentially modulates expression of Fos, Jun and Krox-24 proteins in rat spinal cord neurons. Neuroscience 1994;58:305-21.
25. Tolle TR, Schadrack J, Castro-Lopes JM, Conrad B, Ziegelgansberger W. Baclofen reduces immediate-early gene expression in the rat spinal cord following noxious thermal and inflammatory stimulation. J Neurol 1995; 242S2:45.
26. Kroin JS, Bianchi GD, Penn RD. Intrathecal baclofen down-regulates GABAB receptors in the rat substantia gelatinosa. J Neurosurg 1993;79:544-9.
27. Allerton CA, Boden PR, Hill RG. Actions of GABAB agonist, (-)-baclofen, on neurones in deep dorsal horn of the rat spinal cord in vitro. Br J Pharmacol 1989;96,29-38.
28. Kangrga I, Jiang M, Randic M. Actions of (-)-baclofen on rat dorsal horn neurons. Brain Res 1991;562,265-75.
29. Dressnandt J, Auer C, Conrad B. Influence of baclofen upon the alpha-motoneuron in spasticity by means of F-wave analysis. Muscle Nerve 1995;18:103-7.